Cardiol Therapeutics Inc. (OTCMKTS:CRTPF – Get Free Report)’s stock price rose 1.6% during mid-day trading on Wednesday . The stock traded as high as $1.9550 and last traded at $1.89. 722,278 shares were traded during trading, an increase of 976% from the average session volume of 67,097 shares. The stock had previously closed at $1.86.
Cardiol Therapeutics Stock Up 1.6%
The company’s fifty day moving average is $1.67 and its two-hundred day moving average is $1.36.
About Cardiol Therapeutics
Cardiol Therapeutics Inc is a clinical-stage biotechnology company focused on the development of novel immuno-lipid therapies for treating heart failure and inflammation-related cardiovascular diseases. The company’s proprietary platform is built on synthetic formulations of cardiolipin, a naturally occurring mitochondrial lipid known to play a key role in cellular energy production and inflammatory regulation. By harnessing the anti-inflammatory properties of cardiolipin derivatives, Cardiol aims to address unmet needs in acute and chronic cardiovascular conditions.
Cardiol’s lead product candidate, CT-1 Microspheres, is designed for intravenous administration to hospitalized patients with acute decompensated heart failure.
Recommended Stories
- Five stocks we like better than Cardiol Therapeutics
- Chips to Bots: Qualcomm’s Agentic AI Breakout
- Ciena Fell 40%—Now One Analyst Sees 50% Upside
- Energy Transfer Taps the AI Power Boom
- Viking’s Obesity Edge May Be Staying Power, Not Weight Loss
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
